IPO Price History
Closed
Tatva Chintan Pharma Chem Limited logo

Tatva Chintan Pharma Chem Limited IPO

Mainboard IPOListedTATVANSE
Current Market Price (CMP)
₹1,569.30(+44.90%)
Current Price (CMP)
₹1,569.30(+44.90%)

Live Market Quote

Listing Price & Gain
₹2,111.85(+95.00%)

Day 1 Exchange Open

IPO Issue Price
₹1,083

Band: ₹1073 - ₹1083

Total Subscription
180.36x

Overall Bid Demand

Total Issue Size
—

Gross Public Offer

IPO Schedule & Key Dates

IPO Bidding Opens
16 Jul 2021
IPO Bidding Closes
20 Jul 2021
Allotment & Refunds
Completed
Exchange Listing Day
29 Jul 2021

IPO Subscription Status

Breakdown of institutional, high-net-worth, and retail bidding demand

Overall Demand: 180.36x
Investor CategorySubscriptionDemand Scale
Qualified Institutional Buyers (QIB)185.23x
Non-Institutional Investors (NII / HNI)512.22x
Retail Individual Investors (RII)35.35x
Total Subscription180.36x
Updated as on 20-Jul-2021 17:00:00

Listing Day & Return Performance

Listing Day Gain+95.00%
₹1,083 (Issue) → ₹2,111.85 (List)
Per share profit: +₹1028.85
Holding Return (Till Date)+44.90%
₹1,083 (Issue) → ₹1,569.30 (CMP)
Net gain per share: +₹486.30
Post-Listing Performance (Listing Day → Today):-25.69%

About Tatva Chintan Pharma Chem Limited IPO

Tatva Chintan Pharma Chem Limited is an Indian public offering categorized under the Mainboard segment. The public issue opened for bidding on 16 Jul 2021 and concluded on 20 Jul 2021, offering equity shares to institutional, non-institutional, and retail investors with an indicative price band of ₹1073 - ₹1083.

During the bidding window, Tatva Chintan Pharma Chem Limited witnessed heavy demand with an overall subscription of 180.36 times. Institutional investors (QIB) subscribed 185.23x, non-institutional high-net-worth investors (NII) subscribed 512.22x, and retail individual investors (RII) bid 35.35x their reserved quota.

The equity shares of Tatva Chintan Pharma Chem Limited officially debuted on the stock exchanges on 29 Jul 2021 at an opening listing price of ₹2,111.85, delivering a listing day return of +95.00% (premium) over the final issue price. As per the latest market data, the stock trades at ₹1,569.30, representing an overall gain of +44.90% since its IPO allotment.

Frequently Asked Questions

What was the issue price or price band of Tatva Chintan Pharma Chem Limited IPO?
The issue price of Tatva Chintan Pharma Chem Limited IPO was fixed at ₹1,083 per equity share. The indicative bidding price band was ₹1073 - ₹1083.
What were the open, close, and listing dates for Tatva Chintan Pharma Chem Limited IPO?
Tatva Chintan Pharma Chem Limited IPO opened on 16 Jul 2021, closed on 20 Jul 2021, listed on 29 Jul 2021.
How much was Tatva Chintan Pharma Chem Limited IPO subscribed?
The IPO received an overall subscription of 180.36 times. Category-wise, QIBs subscribed 185.23x, NIIs subscribed 512.22x, and Retail investors subscribed 35.35x.
What was the listing price and listing gain of Tatva Chintan Pharma Chem Limited IPO?
Tatva Chintan Pharma Chem Limited IPO listed on the stock exchange at ₹2,111.85, delivering a listing gain of 95.00% compared to the IPO issue price of ₹1,083.
Is Tatva Chintan Pharma Chem Limited IPO a Mainboard or SME IPO?
Tatva Chintan Pharma Chem Limited IPO is a Mainboard IPO listed on the main exchange of NSE.
What is the current return of Tatva Chintan Pharma Chem Limited IPO since its IPO?
At the latest market quote of ₹1,569.30, Tatva Chintan Pharma Chem Limited IPO has generated an all-time return of +44.90% since its initial public offering.

Related Mainboard IPOs (2021)

CMSINFO
CMS Info Systems Limited
₹216+1.94%
SUPRIYA
Supriya Lifescience Limited
₹274+53.65%
HPAL
HP Adhesives Limited
₹274-77.01%
DATAPATTNS
Data Patterns (India) Limited
₹585+46.33%